Market News

Valinor Management Has Boosted Facebook (FB) Position by $12.10 Million; Nelson Van Denburg & Campbell Wealth Management Group Cut Its Pfizer Com (PFE) Holding by $335,118 as Stock Declined

Nelson Van Denburg & Campbell Wealth Management Group Llc decreased its stake in Pfizer Inc Com (PFE) by 14.97% based on its latest 2017Q3 regulatory filing with the SEC. Nelson Van Denburg & Campbell Wealth Management Group Llc sold 7,979 shares as the company’s stock declined 3.45% while stock markets rallied. The institutional investor held 45,313 shares of the health care company at the end of 2017Q3, valued at $1.94 million, down from 53,292 at the end of the previous reported quarter. Nelson Van Denburg & Campbell Wealth Management Group Llc who had been investing in Pfizer Inc Com for a number of months, seems to be less bullish one the $220.19B market cap company. The stock decreased 0.14% or $0.05 during the last trading session, reaching $36.94. About 29.54M shares traded or 85.47% up from the average. Pfizer Inc. (NYSE:PFE) has declined 2.76% since January 20, 2017 and is downtrending. It has underperformed by 19.46% the S&P500.

David Gallo increased its stake in Facebook Inc (FB) by 9.04% based on its latest 2017Q3 regulatory filing with the SEC. Valinor Management Llc bought 71,200 shares as the company’s stock rose 10.88% with the market. The hedge fund run by David Gallo held 858,575 shares of the technology company at the end of 2017Q3, valued at $146.70 million, up from 787,375 at the end of the previous reported quarter. Valinor Management Llc who had been investing in Facebook Inc for a number of months, seems to be bullish on the $526.79B market cap company. The stock increased 0.83% or $1.49 during the last trading session, reaching $181.29. About 26.83 million shares traded or 49.32% up from the average. Facebook, Inc. (NASDAQ:FB) has risen 26.75% since January 20, 2017 and is uptrending. It has outperformed by 10.05% the S&P500.

Among 53 analysts covering Facebook (NASDAQ:FB), 49 have Buy rating, 2 Sell and 2 Hold. Therefore 92% are positive. Facebook had 220 analyst reports since July 21, 2015 according to SRatingsIntel. On Friday, September 23 the stock rating was initiated by Loop Capital with “Buy”. Cowen & Co maintained Facebook, Inc. (NASDAQ:FB) rating on Thursday, July 27. Cowen & Co has “Buy” rating and $19500 target. Canaccord Genuity maintained the stock with “Buy” rating in Tuesday, September 5 report. The firm has “Buy” rating given on Thursday, July 30 by Deutsche Bank. Axiom Capital maintained it with “Buy” rating and $155 target in Thursday, April 28 report. JP Morgan maintained it with “Overweight” rating and $175 target in Tuesday, September 27 report. As per Thursday, July 13, the company rating was maintained by BMO Capital Markets. The firm earned “Outperform” rating on Thursday, January 28 by RBC Capital Markets. On Tuesday, January 2 the stock rating was maintained by Canaccord Genuity with “Buy”. The rating was maintained by Jefferies on Thursday, July 27 with “Buy”.

Investors sentiment decreased to 1.15 in 2017 Q3. Its down 0.25, from 1.4 in 2017Q2. It fall, as 53 investors sold FB shares while 618 reduced holdings. 128 funds opened positions while 644 raised stakes. 1.63 billion shares or 0.88% more from 1.62 billion shares in 2017Q2 were reported. Cibc Asset Mgmt Inc has 387,524 shares. Convergence Investment Prtnrs Limited Liability Com stated it has 25,059 shares. Saratoga Research Invest Mngmt reported 500 shares. Provident Tru Co reported 1,932 shares. Moreover, Sterneck Cap Mngmt has 2.2% invested in Facebook, Inc. (NASDAQ:FB). Lvw Ltd has 1,903 shares for 0.13% of their portfolio. Hamilton Lane Advsrs Ltd Liability Corp has 11.94% invested in Facebook, Inc. (NASDAQ:FB). Seabridge Inv Advisors Ltd Liability accumulated 0.06% or 1,473 shares. Cohen Klingenstein stated it has 0.72% of its portfolio in Facebook, Inc. (NASDAQ:FB). Ithaka Group Ltd Com accumulated 245,561 shares or 7.71% of the stock. Sequoia Advsrs Ltd Liability Com owns 9,541 shares. Azimuth Capital Mngmt Ltd Co holds 0.88% of its portfolio in Facebook, Inc. (NASDAQ:FB) for 68,684 shares. 56,400 are owned by Gruss & Inc. Dillon & Assoc Incorporated holds 1.75% of its portfolio in Facebook, Inc. (NASDAQ:FB) for 26,004 shares. Calamos Wealth Management Limited Company stated it has 0.65% of its portfolio in Facebook, Inc. (NASDAQ:FB).

Since August 7, 2017, it had 0 buys, and 39 selling transactions for $957.86 million activity. Schroepfer Michael Todd also sold $7.14 million worth of Facebook, Inc. (NASDAQ:FB) shares. Shares for $806,019 were sold by FISCHER DAVID B.. $42.50M worth of Facebook, Inc. (NASDAQ:FB) was sold by Zuckerberg Mark on Monday, August 14. The insider Cox Christopher K sold 16,000 shares worth $2.72 million. Wehner David M. sold $2.59M worth of stock or 15,470 shares. Koum Jan sold $502.59M worth of stock or 2.95M shares.

Valinor Management Llc, which manages about $4.82 billion and $3.19B US Long portfolio, decreased its stake in Restaurant Brands Intl Inc by 61,706 shares to 3.29 million shares, valued at $210.28M in 2017Q3, according to the filing. It also reduced its holding in Adient Plc by 1.21 million shares in the quarter, leaving it with 582,873 shares, and cut its stake in Liberty Global Plc (NASDAQ:LBTYK).

Since August 4, 2017, it had 0 insider purchases, and 10 sales for $16.36 million activity. Another trade for 7,350 shares valued at $249,900 was made by MACKENZIE ALEXANDER R on Thursday, August 31. Another trade for 197,168 shares valued at $6.70M was made by READ IAN C on Thursday, August 31. Another trade for 38,230 shares valued at $1.34 million was sold by SUSMAN SALLY. JOHNSON RADY A had sold 8,000 shares worth $296,560. $3.21 million worth of Pfizer Inc. (NYSE:PFE) shares were sold by DAMELIO FRANK A.

Among 21 analysts covering Pfizer (NYSE:PFE), 9 have Buy rating, 1 Sell and 11 Hold. Therefore 43% are positive. Pfizer had 68 analyst reports since July 29, 2015 according to SRatingsIntel. As per Tuesday, May 16, the company rating was downgraded by Citigroup. The firm has “Market Perform” rating given on Wednesday, November 2 by BMO Capital Markets. The rating was upgraded by Cowen & Co to “Outperform” on Tuesday, October 20. The rating was maintained by Cowen & Co on Monday, September 18 with “Buy”. The stock of Pfizer Inc. (NYSE:PFE) has “Hold” rating given on Monday, October 16 by SunTrust. The firm has “Outperform” rating by BMO Capital Markets given on Thursday, October 19. As per Friday, April 28, the company rating was maintained by BMO Capital Markets. The rating was maintained by Piper Jaffray with “Overweight” on Friday, August 28. The stock of Pfizer Inc. (NYSE:PFE) has “Hold” rating given on Wednesday, April 6 by Societe Generale. The firm has “Overweight” rating given on Tuesday, November 29 by Barclays Capital.

Analysts await Pfizer Inc. (NYSE:PFE) to report earnings on January, 30. They expect $0.56 earnings per share, up 19.15% or $0.09 from last year’s $0.47 per share. PFE’s profit will be $3.34B for 16.49 P/E if the $0.56 EPS becomes a reality. After $0.67 actual earnings per share reported by Pfizer Inc. for the previous quarter, Wall Street now forecasts -16.42% negative EPS growth.

Nelson Van Denburg & Campbell Wealth Management Group Llc, which manages about $183.81 million and $304.07 million US Long portfolio, upped its stake in Vanguard High Dividend Yield Index Fund (VYM) by 10,274 shares to 69,668 shares, valued at $5.65 million in 2017Q3, according to the filing. It also increased its holding in Vanguard Mid (VOT) by 2,966 shares in the quarter, for a total of 70,861 shares, and has risen its stake in Walgreens Boots Alliance Inc Com.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Leave a Reply

Your email address will not be published. Required fields are marked *